LakeShore Biopharma Co (FRA:H6Z0) Total Liabilities: €110.74 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:H6Z0 LakeShore Biopharma Co Ltd FRA:H6Z0
17 GF Score
Price €0.67
View Full Analysis

What is LakeShore Biopharma Co Total Liabilities?

LakeShore Biopharma Co FRA:H6Z0 17 Total Liabilities is €110.74 Mil as of Mar. 2025. GuruFocus rates FRA:H6Z0 with a GF Score™ of 17/100.

LakeShore Biopharma Co's Total Liabilities for the quarter that ended in Mar. 2025 was €110.74 Mil.

LakeShore Biopharma Co's quarterly Total Liabilities declined from Mar. 2024 (€118.53 Mil) to Sep. 2024 (€105.70 Mil) but then increased from Sep. 2024 (€105.70 Mil) to Mar. 2025 (€110.74 Mil).

LakeShore Biopharma Co's annual Total Liabilities declined from Mar. 2023 (€134.36 Mil) to Mar. 2024 (€118.53 Mil) and declined from Mar. 2024 (€118.53 Mil) to Mar. 2025 (€110.74 Mil).

LakeShore Biopharma Co Total Liabilities Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Total Liabilities Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Total Liabilities
216.23 306.37 134.36 118.53 110.74

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Total Liabilities Get a 7-Day Free Trial Premium Member Only 134.36 135.35 118.53 105.70 110.74
FRA:H6Z0
17GF Score
LakeShore Biopharma Co Ltd FRA:H6Z0
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LakeShore Biopharma Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

LakeShore Biopharma Co's Total Liabilities for the fiscal year that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=105.237+(2.999+0.44
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.068+0+0)
=110.74

Total Liabilities=Total Assets (A: Mar. 2025 )-Total Equity (A: Mar. 2025 )
=174.512-63.768
=110.74

LakeShore Biopharma Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=105.237+(2.999+0.44
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+2.068+0+0)
=110.74

Total Liabilities=Total Assets (Q: Mar. 2025 )-Total Equity (Q: Mar. 2025 )
=174.512-63.768
=110.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €110.74 Mil mean?
LakeShore Biopharma Co (FRA:H6Z0) has a Total Liabilities of €110.74 Mil as of Mar. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Total Liabilities too high?
LakeShore Biopharma Co's current Total Liabilities is €110.74 Mil. Overall, LakeShore Biopharma Co has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does LakeShore Biopharma Co's Total Liabilities compare to ACUT and PPCB?
LakeShore Biopharma Co's Total Liabilities of €110.74 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Total Liabilities is €110.74 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (FRA:H6Z0) has a current Total Liabilities of €110.74 Mil. The current Total Liabilities is €110.74 Mil. LakeShore Biopharma Co's overall GF Score™ is 17/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For LakeShore Biopharma Co (FRA:H6Z0), the current Total Liabilities is €110.74 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Other Exchanges LSBCF:USA
Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.
17GF Score

Get the complete analysis for FRA:H6Z0

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.67
Price